JOSÉ ANTONIO LÓPEZ MORENO-rekin lankidetzan egindako argitalpenak (17)

2022

  1. Gut microbiota and voluntary alcohol consumption

    Translational Psychiatry, Vol. 12, Núm. 1

  2. Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission

    IJID Regions, Vol. 4, pp. 10-16

2021

  1. The immune system through the lens of alcohol intake and gut microbiota

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2016

  1. Effects of adolescent intermittent alcohol exposure on the expression of endocannabinoid signaling-related proteins in the spleen of young adult rats

    PLoS ONE, Vol. 11, Núm. 9

  2. Nalmefene is effective at reducing alcohol seeking, treating alcohol-cocaine interactions and reducing alcohol-induced histone deacetylases gene expression in blood

    British Journal of Pharmacology, pp. 2490-2505

2015

  1. Common single nucleotide variants underlying drug addiction: More than a decade of research

    Addiction Biology, Vol. 20, Núm. 5, pp. 845-871

  2. Histone Deacetylase Gene Expression Following Binge Alcohol Consumption in Rats and Humans

    Alcoholism: Clinical and Experimental Research, Vol. 39, Núm. 10, pp. 1939-1950

2014

  1. Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results

    Drug Design, Development and Therapy, Vol. 8, pp. 263-277

  2. Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex

    British Journal of Pharmacology, Vol. 171, Núm. 12, pp. 3023-3036

2012

  1. Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: The effects on immediate-early gene expression in the rat prefrontal cortex

    Neuropharmacology, Vol. 63, Núm. 6, pp. 927-935

2011

  1. Additive effects of cannabinoid CB1 receptors blockade and cholecystokinin on feeding inhibition

    Pharmacology Biochemistry and Behavior, Vol. 98, Núm. 2, pp. 220-226

2010

  1. Functional interactions between endogenous cannabinoid and opioid systems: Focus on alcohol, genetics and drug-addicted behaviors

    Current Drug Targets, Vol. 11, Núm. 4, pp. 406-428

2008

  1. Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2

    Neuroscience Letters, Vol. 433, Núm. 1, pp. 1-5

  2. Implication of the endocannabinoid system in the locomotor hyperactivity associated with congenital hypothyroidism

    Endocrinology, Vol. 149, Núm. 5, pp. 2657-2666

2005

  1. Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats

    Behavioural Pharmacology, Vol. 16, Núm. 5-6, pp. 441-446

2004

  1. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation

    Journal of Neuroscience, Vol. 24, Núm. 38, pp. 8245-8252

  2. Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement

    Neuropharmacology, Vol. 47, Núm. 7, pp. 1036-1044